Telix Pharmaceuticals Limited (TLX)

NASDAQ: TLX · Real-Time Price · USD

9.85

+0.07 (0.72%)

At close: Dec 5, 2025, 4:00 PM EST

9.89

+0.04 (0.41%)

After-hours: Dec 5, 2025, 7:34 PM EST

Telix Pharmaceuticals Market Cap

Telix Pharmaceuticals has a market cap or net worth of $3.33 billion as of December 5, 2025. Its market cap has decreased by -32.75% in one year.

Market Cap

3.33B

Enterprise Value

3.54B

1-Year Change

-32.75%

Ranking

#1656

Market Cap Chart

Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.33B, an increase of 2,785.74%. That is a compound annual growth rate of 51.76%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	3.33B	-34.75%
Dec 31, 2024	5.10B	129.18%
Dec 29, 2023	2.22B	42.30%
Dec 30, 2022	1.56B	-2.70%
Dec 31, 2021	1.61B	96.45%
Dec 31, 2020	817.72M	196.48%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	904.62B
Johnson & Johnson	486.51B
AbbVie	399.57B
UnitedHealth Group	299.75B
AstraZeneca	280.82B
Novartis AG	255.15B
Merck & Co.	247.51B
Abbott Laboratories	217.50B

Market Cap Rankings